Marianna Meschiari, Shaniko Kaleci, Martina Del Monte, Andrea Dessilani, Antonella Santoro, Francesco Scialpi, Erica Franceschini, Gabriella Orlando, Adriana Cervo, Morselli Monica, Fabio Forghieri, Claudia Venturelli, Enrico Ricchizzi, Johanna Chester, Mario Sarti, Giovanni Guaraldi, Mario Luppi, Cristina Mussini
BACKGROUND: Vancomycin-resistant enterococcus (VRE) was the fastest growing pathogen in Europe in 2022 (+ 21%) but its clinical relevance is still unclear. We aim to identify risk factors for acquired VRE rectal colonization in hematological patients and evaluate the clinical impact of VRE colonization on subsequent infection, and 30- and 90-day overall mortality rates, compared to a matched control group. METHODS: A retrospective, single center, case-control matched study (ratio 1:1) was conducted in a hematological department from January 2017 to December 2020...
November 13, 2023: Antimicrobial Resistance and Infection Control